|
||||||
Executive Summary Karo Pharma AB (KARO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description-A detailed description of the company's operations and business divisions. - Corporate strategy-Analyst's summarization of the company's business strategy. - SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats. - Company history-Progression of key events associated with the company. - Major products and services-A list of major products, services and brands of the company. - Key competitors-A list of key competitors to the company. - Key employees-A list of the key executives of the company. - Executive biographies-A brief summary of the executives' employment history. - Key operational heads-A list of personnel heading key departments/functions. - Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities-A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases including autoimmune diseases such as multiple sclerosis; and multiple types of cancer, viral and bacterial infections. The company's projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden. Karo Pharma AB Key Recent Developments Apr 26,2018: Karo Pharma Doubles Sales and Earnings in the First Quarter Mar 23,2018: Karo Pharma Supports Operation Smile Mar 01,2018: LEO Pharma sells portfolio of 10 products to Karo Pharma Feb 22,2018: Karo Pharma: Year-end Report 2017 Nov 02,2017: Karo Pharma: Interim Report January- September 2017 Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Read More Contact Us:
Table of Contents Table of Contents 3 List of Tables 5 List of Figures 5 Section 1-About the Company 6 Karo Pharma AB-Key Facts 6 Karo Pharma AB-Key Employees 7 Karo Pharma AB-Key Employee Biographies 8 Karo Pharma AB-Key Operational Employees 9 Karo Pharma AB-Major Products and Services 10 Karo Pharma AB-History 11 Karo Pharma AB-Company Statement 14 Karo Pharma AB-Locations And Subsidiaries 15 Head Office 15 Other Locations & Subsidiaries 15 Section 2-Company Analysis 16 Company Overview 16 Karo Pharma AB-Business Description 17 R&D Overview 17 Karo Pharma AB-Corporate Strategy 18 Karo Pharma AB-SWOT Analysis 19 SWOT Analysis-Overview 19 Karo Pharma AB-Strengths 19 Karo Pharma AB-Weaknesses 20 Karo Pharma AB-Opportunities 21 Karo Pharma AB-Threats 22 Karo Pharma AB-Key Competitors 23 Section 3-Company Financial Ratios 24 Financial Ratios-Capital Market Ratios 24 Financial Ratios-Annual Ratios 25 Performance Chart 28 Financial Performance 28 Financial Ratios-Interim Ratios 29 Financial Ratios-Ratio Charts 30 Section 4-Company's Lifesciences Financial Deals and Alliances 31 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32 Karo Pharma AB, Recent Deals Summary 33 Section 5-Company's Recent Developments 34 Apr 26, 2018: Karo Pharma Doubles Sales and Earnings in the First Quarter 34 Mar 23, 2018: Karo Pharma Supports Operation Smile 35 Mar 01, 2018: LEO Pharma sells portfolio of 10 products to Karo Pharma 36 Feb 22, 2018: Karo Pharma: Year-end Report 2017 37 Nov 02, 2017: Karo Pharma: Interim Report January- September 2017 38 Aug 24, 2017: Karo Pharma: Interim Report January-June 2017 40 May 10, 2017: Karo Pharma: interim report January-March-2017 41 Feb 28, 2017: Karo Pharma: Full Year Report 2016 42 Section 6-Appendix 43 Methodology 43 Ratio Definitions 43 About GlobalData 47 Contact Us 47 Disclaimer 47 List of Figures Karo Pharma AB, Performance Chart (2013-2017) 28 Karo Pharma AB, Ratio Charts 30 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32 List of Tables Karo Pharma AB, Key Facts 6 Karo Pharma AB, Key Employees 7 Karo Pharma AB, Key Employee Biographies 8 Karo Pharma AB, Key Operational Employees 9 Karo Pharma AB, Major Products and Services 10 Karo Pharma AB, History 11 Karo Pharma AB, Subsidiaries 15 Karo Pharma AB, Key Competitors 23 Karo Pharma AB, Ratios based on current share price 24 Karo Pharma AB, Annual Ratios 25 Karo Pharma AB, Annual Ratios (Cont...1) 26 Karo Pharma AB, Annual Ratios (Cont...2) 27 Karo Pharma AB, Interim Ratios 29 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32 Karo Pharma AB, Recent Deals Summary 33 Currency Codes 43 Capital Market Ratios 43 Equity Ratios 44 Profitability Ratios 44 Cost Ratios 45 Liquidity Ratios 45 Leverage Ratios 46 Efficiency Ratios 46 Single User License: Site License: Corporate User License: Active Biotech AB Nuevolution AB Genmab A/S BioInvent International AB Meda AB Dyax Corp Karo Pharma AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |